Edition:
United States

IBEX Technologies Inc (IBT.V)

IBT.V on TSX Venture Exchange

0.23CAD
--
Change (% chg)

-- (--)
Prev Close
$0.23
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
9,865
52-wk High
$0.26
52-wk Low
$0.08

IBT.V

Chart for IBT.V

About

IBEX Technologies Inc., through its subsidiaries, IBEX Pharmaceuticals Inc. and BioResearch Products Inc., manufactures and markets enzymes for biomedical use. The Company also manufactures and markets a series of arthritis assays, which enable the study of both the synthesis and degradation of cartilage components. It operates... (more)
No analyst recommendations are available for IBT.V.

Overall

Beta: -0.17
Market Cap(Mil.): $5.68
Shares Outstanding(Mil.): 24.70
Dividend: --
Yield (%): --

Financials

  IBT.V Industry Sector
P/E (TTM): 9.04 78.89 32.56
EPS (TTM): 0.03 -- --
ROI: 10.15 2.83 14.89
ROE: 12.35 5.09 16.13

BRIEF-Ibex reports Q3 results

* Ibex reports results for the third quarter and the nine months ended April 30, 2017 Source text for Eikon: Further company coverage:

Jun 19 2017

Earnings vs. Estimates

No consensus analysis data available.